Fiche publication
Date publication
septembre 2026
Journal
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Auteurs
Membres identifiés du Cancéropôle Est :
Dr AMARAL Teresa Maria
Tous les auteurs :
Nanz L, Garbe C, Reitmajer M, Forschner A, Maczey-Leber Y, Amaral T, Flatz L, Leiter U
Lien Pubmed
Résumé
Systemic treatment of cutaneous melanoma has changed since 2011, with clinical studies demonstrating improved outcomes. This analysis evaluated whether this improvement is evident in a real-world cohort, focusing on overall survival (OS) and relapse-free survival (RFS).
Mots clés
Cutaneous melanoma, immune checkpoint inhibitors, improvement, overall survival, relapse‐free survival, targeted therapy
Référence
J Dtsch Dermatol Ges. 2026 09 7;:
